FLUORINOV PHARMA
FLUORINOV PHARMA
Industry:
Biotechnology
Founded:
2008-01-01
Website Url:
http://www.fluorinovpharma.com
Total Employee:
11+
Status:
Closed
Technology used in webpage:
Domain Not Resolving
Official Site Inspections
http://www.fluorinovpharma.com
Unable to get host informations!!!
More informations about "Fluorinov Pharma"
Fluorinov Pharma - Crunchbase Company Profile & Funding
Organization. Fluorinov Pharma . Connect to CRM . Save . Summary. People. Technology. Signals & News. About. Fluorinov Pharma Inc., a privately-held oncology company. ...See details»
Fluorinov Pharma Company Profile 2024: Valuation, Investors ...
Fluorinov Pharma General Information Description. Operator of a pharmaceutical company intended to develop fluorine-based novel, safer and more effective medicine. The company's โฆSee details»
Fluorinov Pharma, Inc. - Drug pipelines, Patents, Clinical trials
Explore Fluorinov Pharma, Inc. with its drug pipeline, therapeutic area, technology platform, 9 literature, Drug:FV-009.See details»
Fluorinov Pharma Inc - Company Profile and News
Fluorinov Pharma Inc., is a pharmaceutical company. The Company researches and develops novel drugs for the treatment of cancers and central nervous system disorders. ...See details»
Fluorinov Pharma Inc. develops drug for the treatment of blood
Fluorinov Pharma Inc. Fluorinov Pharma is a privately owned biopharmaceutical company that initiated discovery operations in Toronto, Canada in 2008. Fluorinov rapidly discovers and โฆSee details»
Fluorinov Pharma Inc Company Profile | Toronto, ON, Canada ...
Find company research, competitor information, contact details & financial data for Fluorinov Pharma Inc of Toronto, ON. Get the latest business insights from Dun & Bradstreet. D&B โฆSee details»
Fluorinov, FACIT and OICR announce novel candidate drugs
TORONTO, ON (April 24, 2014) โ Fluorinov Pharma, an emerging Ontario-based drug development company, has developed three structurally distinct candidate drugs that โฆSee details»
Trillium Therapeutics Acquires Fluorinov Pharma - Ontario โฆ
Jan 28, 2016 Combined entity creates strong foundation for leading Canadian immuno-oncology company TORONTO, ON (January 28, 2016) โ FACIT has announced that Trillium โฆSee details»
Trillium Therapeutics Acquires Fluorinov Pharma - FACIT
Trillium Therapeutics Acquires Fluorinov Pharma Combined entity creates strong foundation for leading Canadian immuno-oncology company. TORONTO, ON (January 28, 2016) โ FACIT has announced that Trillium Therapeutics Inc. โฆSee details»
Trillium Therapeutics Acquires Fluorinov Pharma - Newswire
Jan 28, 2016 /CNW/ - FACIT has announced that Trillium Therapeutics Inc. (NASDAQ:TRIL, TSX:TR; "Trillium") has acquired all of the outstanding shares of privately-held...See details»
Trillium Acquires Privately-Held Fluorinov Pharma Inc.
Jan 27, 2016 Trillium Acquires Privately-Held Fluorinov Pharma Inc. - Proprietary industry-leading fluorine-based medicinal chemistry platform providing an internal engine to generate โฆSee details»
Trillium Acquires Fluorinov - Technology Networks
Jan 28, 2016 Trillium Therapeutics Inc. a clinical immuno-oncology company developing innovative therapies for the treatment of cancer, has announced that it has acquired all of the โฆSee details»
OICR Funds Fluorinov Pharma Inc To Further Develop Its Novel โฆ
The Ontario Institute for Cancer Research (OICR) today announced $1.5 million in funding over three years for the development of a new drug by Toronto-based Fluorinov Pharma, Inc. The โฆSee details»
OICR funds Fluorinov Pharma Inc. to further develop its
Jun 7, 2012 /CNW/ - The Ontario Institute for Cancer Research (OICR) today announced $1.5 million in funding over three years for the development of a new drug by...See details»
Fluorinov Pharma, FACIT and OICR announce novel candidate
Apr 24, 2014 /CNW/ - Fluorinov Pharma, an emerging Ontario-based drug development company, has developed three structurally distinct candidate drugs that selectively target...See details»
Fluorinov Pharma and FACIT Announce Investment in โฆ
Jan 7, 2015 About Fluorinov Pharma The incorporation of fluorine into drug structures can improve potency, stability and safety, and other critical drug attributes. Innovative โฆSee details»
Fluorinov Pharma and FACIT Announce Investment in โฆ
TORONTO, ON (January 07, 2015) โ FACIT and Fluorinov Pharma announced today an investment in the development of highly potent inhibitors of key bromodomain targets. โฆSee details»
Research programme: fluorinated CNS and cancer therapeutics
Originator Fluorinov Pharma Developer Trillium Therapeutics Inc Class ... Contacting your organizationโs admin about adding this content to your AdisInsight subscription Buying a PDF โฆSee details»
Trillium Therapeutics Acquires Fluorinov Pharma - PR Newswire
Jan 28, 2016 Combined entity creates strong foundation for leading Canadian immuno-oncology company . TORONTO, Jan. 28, 2016 /PRNewswire/ - FACIT has announced that Trillium โฆSee details»
Fluorinov Pharma and FACIT Announce Investment in โฆ
Jan 7, 2015 /CNW/ - FACIT and Fluorinov Pharma announced today an investment in the development of highly potent inhibitors of key bromodomain targets. Targeting drugs to...See details»